~ Expansion enhances the company’s ability to serve the growing ADC market ~ Michigan, June 21, 2019: Piramal Pharma Solutions (PPS),…
Mumbai, March 13, 2019: Piramal Enterprises Limited (‘PEL’, ‘Piramal’, NSE: PEL, BSE: 500302) announced that one of its partnersfor its global…
Chennai, November 22, 2018: Piramal Pharma Solutions (PPS), a leading Contract Development and Manufacturing Organization (CDMO) announced the completion of…
Novel payloads that target tumour-initiating cells on third generation ADCs could come to market in the next couple of years…
Winners will be announced live at the Gala Ceremony in Madrid with over 500 of Pharma’s top executives. Amsterdam, July…